Karoline Baquet-Walscheid
Overview
Explore the profile of Karoline Baquet-Walscheid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baquet-Walscheid K, Ness T, Maier P, Lapp T
Klin Monbl Augenheilkd
. 2024 May;
PMID: 38776976
No abstract available.
2.
Baquet-Walscheid K, Ness T, Maier P, Lapp T
Klin Monbl Augenheilkd
. 2024 May;
241(5):633-643.
PMID: 38776930
Peripheral ulcerative keratitis (PUK) is an inflammatory disease of the peripheral cornea, which may frequently be associated with several rare, but potentially life-threatening systemic diseases. The inflammatory pathogenesis of PUK...
3.
Baquet-Walscheid K, Rath T, Heiligenhaus A
Klin Monbl Augenheilkd
. 2024 Apr;
241(5):626-632.
PMID: 38574680
Ocular manifestations of rheumatic diseases are common and contribute significantly to the morbidity and reduced quality of life of affected patients. Knowledge of typical clinical manifestations is important for the...
4.
Heinz C, Baquet-Walscheid K
Klin Monbl Augenheilkd
. 2023 Nov;
240(12):1433-1447.
PMID: 37977203
Intermediate and posterior uveitis describes a broad variety of different types of intraocular inflammation. Before starting treatment of intermediate or posterior uveitis, a differentiation between infectious or non-infectious uveitis must...
5.
Baquet-Walscheid K, Heinz C
Klin Monbl Augenheilkd
. 2023 Nov;
241(1):119-135.
PMID: 37977201
Intermediate and posterior uveitis can have multiple infectious and noninfectious causes, and posterior uveitis in particular is clinically multifaceted. Some entities require prompt initiation of therapy to ensure visual prognosis....
6.
Glandorf K, Rothaus K, Baquet-Walscheid K, Heinz C, Heiligenhaus A
Ocul Immunol Inflamm
. 2023 Mar;
32(5):636-641.
PMID: 36898006
Purpose: Patients with juvenile idiopathic arthritis (JIA) associated uveitis (JIAU) are at risk for secondary glaucoma, frequently requiring surgical management. We compared the success rates for trabeculectomy (TE) and Ahmed...
7.
Baquet-Walscheid K, Heinz C, Heiligenhaus A
Ocul Immunol Inflamm
. 2022 Nov;
32(6):1076-1078.
PMID: 36442052
Noninfectious scleritis typically takes a chronic course, and systemic corticosteroids or disease-modifying anti-rheumatic drug (DMARD) treatment may be inevitable for a prolonged period. Janus kinase (JAK) inhibitors are a relatively...
8.
Foeldvari I, Maccora I, Petrushkin H, Rahman N, Anton J, de Boer J, et al.
Arthritis Care Res (Hoboken)
. 2022 May;
75(5):975-982.
PMID: 35638697
Objective: The Multinational Interdisciplinary Working Group for Uveitis in Childhood identified the need to update the current guidelines, and the objective here was to produce this document to guide clinicians...
9.
Baquet-Walscheid K, Heinz C, Rath T, Scheel M, Heiligenhaus A
Ocul Immunol Inflamm
. 2022 May;
31(5):1079-1080.
PMID: 35587645
Objective: Several case reports have been published on the effect of janus kinase inhibitors (JAK-I) on juvenile idiopathic arthritis-associated uveitis (JIAU). Both tofacitinib and baricitinib have been described as therapeutically...
10.
Baquet-Walscheid K, Wildschutz L, Kasper M, Busch M, Thanos S, Bauer D, et al.
Mol Biol Rep
. 2022 Apr;
49(7):6093-6102.
PMID: 35359237
Purpose: Juvenile idiopathic arthritis-associated uveitis (JIAU) may run a chronic and treatment-resistant course, and occasionally, alterations of the iris vasculature may be observed clinically. Methods: Iris tissue (IT), aqueous humor...